African American Cancer Survivors’ Perspectives on Cancer Clinical Trial Participation in a Safety-Net Hospital: Considering the Role of the Social Determinants of Health
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Although there has been an increase focus on recruitment of minority populations at safety-net hospitals into cancer clinical trials, there is still a paucity of research exploring minority participation in cancer clinical trials at safety-net settings. The study utilized a multi-level, qualitative approach to assess the clinical and non-clinical facilitators and barriers to African American participation in cancer clinical trials at a safety-net hospital. From June 2018 to July 2019, cancer survivors (n = 25) were recruited from a cancer center at a safety-net hospital in the southeastern USA and participated in a 60-min focus group. Data was coded and analyzed to identify the most prominent themes. Most participants were female (78%), with a mean age of 56 years. The majority were diagnosed with breast cancer (68%) and disabled or unemployed (55%). Major themes identified were (1) lack of understanding of cancer clinical trials, (2) perceptions and fears of cancer clinical trials, and (3) preferred role and characteristics of patient navigator. The barriers and facilitators to enrollment in cancer clinical trials were more pronounced in the safety-net setting, given the overdue burden of social determinants of health. Study findings yield important insights and essential practices for recruiting and engaging underrepresented Black cancer patients into cancer clinical trials, specifically for safety-net settings. Including patient navigators may help traverse potential barriers to cancer clinical trial participation and will allow for the attention to social determinants of health, and ultimately increase the number of African Americans participating in cancer clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fourteen studies reported on why certain patients may have been overlooked for clinical trial participation [12, 17, 38, 42, 44, 45, 52–55, 59, 63, 66, 69].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [45]
In the citing paper
“Other studies reported that patients’ initial contact with research staff was crucial. A positive encounter cultivated or renovated trust in healthcare and research, thereby motivating patients to participate in a trial [10, 43, 45].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [45]
In the citing paper
“Three studies highlighted cases where patients believed that clinical trials were part of the regular health services, they were entitled to [10, 33, 45], and previous negative experiences of health services deterred them from participating in trials.”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [45]
Citations
Cites
George, S., Duran, N., & Norris, K. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301706 · Cited by 1,603
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Alcaraz, K. I., Wiedt, T. L., Daniels, E. C., Yabroff, K. R., Guerra, C. E., & Wender, R. C. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21586 · Cited by 530
Chen, M. S., Lara, P. N., Dang, J. H. T., Paterniti, D. A., & Kelly, K. (2014) · Cancer · doi:10.1002/cncr.28575 · Cited by 472
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer
Hamel, L. M., Penner, L. A., Albrecht, T. L., Heath, E., Gwede, C. K., & Eggly, S. (2016) · Cancer Control · doi:10.1177/107327481602300404 · Cited by 463
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Duma, N., Vera Aguilera, J., Paludo, J., Haddox, C. L., Gonzalez Velez, M., Wang, Y., Leventakos, K., Hubbard, J. M., Mansfield, A. S., Go, R. S., et al. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.025288 · Cited by 446
Geller, S. E., Koch, A. R., Roesch, P., Filut, A., Hallgren, E., & Carnes, M. (2018) · Academic Medicine · doi:10.1097/acm.0000000000002027 · Cited by 314
Influence of Clinical Communication on Patients' Decision Making on Participation in Clinical Trials
Albrecht, T. L., Eggly, S. S., Gleason, M. E. J., Harper, F. W. K., Foster, T. S., Peterson, A. M., Orom, H., Penner, L. A., & Ruckdeschel, J. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8114 · Cited by 248 · cited 1×
“Previous studies have demonstrated that, when there is clear and understandable shared communication between the physician and patient, decisions to enroll in cancer clinical trials are greatly enhanced [17].”
BackgroundMoorcraft, S. Y., Marriott, C., Peckitt, C., Cunningham, D., Chau, I., Starling, N., Watkins, D., & Rao, S. (2016) · Trials · doi:10.1186/s13063-015-1105-3 · Cited by 236
Jha, A. K., Orav, E. J., & Epstein, A. M. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0027 · Cited by 159
Research works printed but not linked: 1
- Ko NY, Julie Leann F, Lane SC, Finn K, Allten S, Vassilakis N, Stober L, Kachnic L, Battaglia TA (2015) Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital. J Commun Support Oncol 13(12):429–435
Cited by
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
“The reasons driving people from minority ethnic groups who agreed to and continued to participate in clinical trials were discussed in 12 articles [10, 12, 33, 34, 43, 45, 48, 50, 56, 57, 63, 69].”
InfluentialAccess Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer
Eskander, M. F., Gil, L., Beal, E. W., Li, Y., Hamad, A., Oppong, B., Obeng-Gyasi, S., & Tsung, A. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10868-4 · Cited by 35
“However, they may also be less aware of trial opportunities and are less likely to be offered those opportunities due to physician perceptions.(4,15) Language and cultural barriers and lack of translators or translated research materials may also preclude certain populations from joining.”
BackgroundThe Importance of Including Underserved Populations in Research
Mehl, K. R., Morain, S. R., & Largent, E. A. (2025) · Pharmaceutical Medicine · doi:10.1007/s40290-025-00562-1 · Cited by 32
“Partnerships with community health centers and safety-net clinics can bring trials closer to these populations and minimize barriers for uninsured and underinsured populations [36, 70, 72].”
Increasing Clinical Trial Participation of Black Women Diagnosed with Breast Cancer
Fairley, R., Lillard, J. W., Berk, A. R., Cornew, S., Gaspero, J., Gillespie, J., Horne, L. L., Kidane, S., Munro, S. B., Parsons, M., et al. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01644-z · Cited by 15
“Apprehension based on cultural differences, perceptions of discrimination, or medical mistrust have also been attributed to patients’ decisions not to participate in clinical trials [31–34].”
BackgroundKumar, G., Kim, J., Farazi, P. A., Wang, H., & Su, D. (2022) · BMC Cancer · doi:10.1186/s12885-022-10082-9 · Cited by 14
“The study reported that many survivors were confused and even could not be differentiated between a cancer clinical trial and treatment of cancer [31].”
Background
Metadata
- Authors
- Hernandez, N. D., Durant, R., Lisovicz, N., Nweke, C., Belizaire, C., Cooper, D., Soiro, F., Rivers, D., Sodeke, S., & Rivers, B. M.
- Affiliations
- Morehouse School of Medicine (US)
- University of Alabama at Birmingham (US)
- Brandeis University (US)
- Tuskegee University (US)
- Corresponding author
- Hernandez, N. D.
- Venue
- Journal of Cancer Education
- Published
- 2021-03-16
- Volume
- 37
- Issue
- 6
- Pages
- 1589-1597
- ISSN
- 0885-8195 (ISSN-L)
- 1543-0154
- PMC
- PMC8443686
- OpenAlex
- W3139441962
- Semantic Scholar
- 098b1e76a58968d3ce3c7f1126eaa21b43309679
- Cited by
- 26
- References
- 25
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 1 · 2021: 1
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Cancer Education (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Center for Advancing Translational Sciences (UL1TR002378)
- National Cancer Institute (5U54CA118638-13)
- National Institutes of Health (U54CA118948, UL1TR002378, R01 MD007783)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Keywords
- African American cancer survivors, safety-net hospitals, social determinants of health, barriers and facilitators, patient navigators, clinical trial recruitment, breast cancer
- MeSH terms
- Cancer Survivors, Black or African American, Breast Neoplasms, Female, Humans, Male, Middle Aged, Safety-net Providers, Social Determinants of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: African American Cancer Survivors’ Perspectives on Cancer Clinical Trial Participation in a Safety-Net Hospital: Considering the Role of the Social Determinants of Health. https://app.cochat.ai/papers/10.1007/s13187-021-01994-4
- The paper
- Hernandez, N. D., Durant, R., Lisovicz, N., Nweke, C., Belizaire, C., Cooper, D., Soiro, F., Rivers, D., Sodeke, S., & Rivers, B. M. (2022). African American Cancer Survivors’ Perspectives on Cancer Clinical Trial Participation in a Safety-Net Hospital: Considering the Role of the Social Determinants of Health. Journal of Cancer Education. https://doi.org/10.1007/s13187-021-01994-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.